Ultralong-segment Barrett's Esophagus: Towards a Capsule-sponge Surveillance Strategy

NARecruitingINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Barrett Esophagus
Interventions
DEVICE

EndoSign

"The EndoSign cell collection device is a non-endoscopic capsule sponge device used to collect pan-esophageal samples.~The Endosign procedure consists of an expandable, spherical mesh, which is attached to a string and contained within a soluble capsule. Seven minutes after swallowing (once the capsule has dissolved), the spherical mesh, which measures around 3cm in diameter is retrieved by pulling on the string. Upon retrieval the capsule-sponge scrapes against the surface of the top of the stomach and esophagus and collects epithelial cells. The capsule-sponge sample is then placed into a preservative fluid and the specimen is processed for molecular tests."

Trial Locations (1)

1315 GD

RECRUITING

Erasmus Medisch Centrum, Rotterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cyted Health Inc

INDUSTRY

collaborator

University of Cambridge

OTHER

lead

Erasmus Medical Center

OTHER

NCT06720636 - Ultralong-segment Barrett's Esophagus: Towards a Capsule-sponge Surveillance Strategy | Biotech Hunter | Biotech Hunter